• Share
  • Email
  • Print

Janine Jansen

Senior Associate
+61.3.9205.2142
Fax +61.3.9205.2055

Ms. Jansen is a corporate and transactional lawyer with a focus on corporate transactions within the health, aged care/retirement living and therapeutic goods sector.

She has experience in advising a range of local and international clients with respect to mergers and acquisitions, compliance with regulatory requirements, commercial contracting, corporate governance and general commercial work.

Professional Background

Ms. Jansen commenced her career at a large national Australian law firm where part of her time was spent on secondment to Toll Holdings Limited.

Prior to joining K&L Gates, Ms. Jansen resided in Paris, France where she worked as corporate counsel and supervisory board secretary at Europe's leading listed commercial property company, Unibail-Rodamco SE. She also previously spent several years in private practice at a leading international French law firm specializing in cross-border mergers and acquisitions.

Health / Aged Care / Therapeutic Goods

  • Mergers and acquisitions of pharmaceutical companies, medical practices and corporate health service providers and aged care facilities. This includes advising The Salvation Army on what was one of the largest aged care and retirement village asset sales ever to take place in Australia, namely, the sale of 15 retirement villages and aged care centres in Victoria, Tasmania, South Australia, Western Australia and the Northern Territory (a critical part of this advice was consideration of matters relevant to the redevelopment of retirement villages and aged care facilities). 
  • Regulatory advice with respect to the inclusion of goods on the Australian Register of Therapeutic Goods, the administration and reporting requirements relating to clinical trials, the wholesaling of drugs and poisons and the licensing and regulatory framework regarding the sale and manufacture of diagnostic imaging machinery in Australia. 
  • Corporate and commercial contracting with respect to healthcare and life sciences industries including in relation to the provision of health services and supply and distribution of therapeutic goods.

Corporate and Commercial

Ms. Jansen advised a number of French and international clients while working as a corporate and transactional lawyer for a number of years in Paris, France.

  • Advising a Saudi Arabian real estate developer in the establishment of two polyclinics in a new city in the Kingdom of Saudi Arabia. 
  • Advising Areva SA with respect to the sale of its transmission and distribution business (formerly "Areva T&D Holding SA) to Alstom and Schneider Electric. 
  • Advising Areva SA in its acquisition of a shareholding in STMicroelectronics held by Finmeccanica.
  • Advising Areva SA with respect to Siemens’ exit from the joint venture, Areva NP. 
  • Advising Lafarge in the creation of its joint venture with Strabag SE to operate throughout Central Europe. 
  • Advising Johnson Controls Investments (UK) Ltd in its acquisition of a French company and its subsidiaries throughout South America and Europe. 
  • Advising Steinhoff International Holdings Ltd in its acquisition of Conforama Holdings. 
  • Advising a private trust in its acquisition of various shares and assets in Russia, France and the United States of America. 
  • Advising the Kerry Group in its acquisition of the Romanian, Turkish, Polish, Ukrainian and Russian companies of the Dera Group. 
  • Advising the John Wood Group in its acquisition of the French subsidiary of the Marine Computation Services Ltd group. 
  • Advising the Europcar Group with respect to various corporate law matters in the context of a financial restructuring. 
  • Advising on various shareholder agreements, joint venture agreements and corporate law matters. 
  • As in-house corporate counsel, reviewing and drafting various commercial contracts (consultancy agreements, confidentiality agreements, service agreements, internal and external loan agreements, credit facility agreements, ISDA agreements etc.) and developing and maintaining the corporate governance framework of a listed company.